BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ('BioRay') announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed C ...
Richmond-Petersburg WWBT on MSN1h
HCPS to host immunization clinics at all middle and high schools
The school division is partnering with the Virginia Department of Health’s Richmond and Henrico Health Districts to offer a free vaccine clinic ...
Vaccine Technologies Market to Reach $90.6 billion, Globally, by 2033 at 6.4% CAGR: Allied Market Research
The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.